Companies / Information Technology
LRCX
Lam Research
Semiconductor Materials & Equipment
Semiconductor Materials & EquipmentAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health87
Growth84
Profitability93
Cash generation69
Balance sheet97
Dilution control92
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-27)54.4%Revenue growth (FY)26.0%Revenue CAGR (3y)10.1%Gross margin50.5%Operating margin35.3%Net margin31.3%Free cash flow margin21.1%R&D / revenue10.2%Stock comp / revenue1.7%Net debt / operating cash flow-0.32xCurrent ratio2.63Diluted share count change-2.3%
| Fiscal year ending | FY 2022-06 | FY 2023-06 | FY 2024-06 | FY 2025-06 | FY 2026-06 |
|---|---|---|---|---|---|
| Revenue | $17.2B | $17.4B | $14.9B | $18.4B | $23.2B |
| Gross profit | $7.9B | $7.8B | $7.1B | $9.0B | $11.7B |
| Operating income | $5.4B | $5.2B | $4.3B | $5.9B | $8.2B |
| Net income | $4.6B | $4.5B | $3.8B | $5.4B | $7.3B |
| Operating cash flow | $3.1B | $5.2B | $4.7B | $6.2B | $5.9B |
| Capital expenditure | $546M | $502M | $397M | $759M | $966M |
| Free cash flow | $2.6B | $4.7B | $4.3B | $5.4B | $4.9B |
| R&D | $1.6B | $1.7B | $1.9B | $2.1B | $2.4B |
| Stock-based comp | $259M | $287M | $293M | $343M | $386M |
| Buybacks | $3.9B | $2.0B | $2.8B | $3.4B | $3.9B |
| Dividends | $815M | $908M | $1.0B | $1.1B | $1.3B |
| Cash | $3.5B | $5.3B | $5.8B | $6.4B | $5.6B |
| Total debt | $5.0B | $5.0B | $5.5B | $5.2B | $3.7B |
| Equity | $6.3B | $8.2B | $8.5B | $9.9B | $12.5B |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.